More articles from Oncology - Clinical Diagnosis: Solid Tumors

You have access
The impact of FDG-PET/CT in malignant melanoma: A retrospective analysis of 158 consecutive studies
Gabriella Liszkay, Miklos Kasler, Katalin Gilde, Zsuzsa Fejos and Katalin Borbely

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1708;
You have access
Dynamic 18Fluoroethylcholine-PET in primary prostate cancer. Is there a use?
Markus Hartenbach, Sabrina Hartenbach, Winfried Bechtloff, Adrian Sailer, Klaus Kraft, Burkhardt Danz, Christoph Sparwasser and Burkhard Klemenz

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1813;
You have access
Automated detection and assessment of NSCLC using a novel PET/CT software tool: Initial results
Steffen Hahn, Till Heusner, Xiang Zhou, Alexander Stahl, Andreas Bockisch and Gerald Antoch

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1795;
You have access
Which FDG PET/CT quantitative indices (SUVmax, metabolic volume, total lesion glycolysis) correlate well with serum tumor markers in NSCLC, colon cancer and pancreas cancer?
Shigeki Nagamachi, Hideyuki Wakamatsu, Syougo Kiyohara, Seigo Fujita, Ryuichi Nishii, Hideo Arita, Shigemi Futami and Shozo Tamura

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1722;
You have access
The assessment of breast cancer (BC) response to neoadjuvant therapy: A SPECT/CT study
Angela Spanu, Francesca Chessa, Daniela Sanna, Susanna Nuvoli and Giuseppe Madeddu

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1698;
You have access
[18F] FDG PET predicts outcome in NPC treated patients
Jong-Kang Lee, Chih-Yung Chang, Wen-Shan Liu, Rung-Tong Liu and Wen-Sheng Huang

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1782;
You have access
Glucose metabolic phenotyping and prediction of tumor grade in soft tissue and bone tumors by 18F-FDG PET imaging
Matthias Benz, Sarah Dry, Fritz Eilber, David Elashoff, Martin Allen-Auerbach, William Tap, Michael Phelps, Wolfgang Weber and J Czernin

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1731;
You have access
99TcmN-NOET SPECT in detectioning axillary nodes metastasis of pts with breast cancer
Liu Hai-yan, Li Si-jin, Lu Ke-yi and Wu Zhi-fang

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1689;
You have access
Advantages of FDG PET/MRI over PET/CT in evaluating colorectal cancer
Mitsuaki Tatsumi, Kazuya Nakazyo, Ichiro Higuchi, Hiromitsu Onishi, Tonsok Kim, Atsuo Inoue, Eku Shimosegawa and Jun Hatazawa

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1743;
You have access
Molecular remission in mediastinal lymph node metastases after neoadjuvant chemoradiation as detected by F-18 FDG PET: A new prognostic factor for patients with NSCLC stage III?
Michael Schmuecking, R. Baum, V. Prasad, C. Schneider, N. Presselt, J. Leonhardi, K. Mueller, T. Wendt and R. Bonnet

Journal of Nuclear Medicine May 1, 2009, 50 (supplement 2) 1803;

Main menu

User menu

Search

More articles from Oncology - Clinical Diagnosis: Solid Tumors

Pages